Cargando…
Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson's Disease
OBJECTIVE: To research the effect of different 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration intervals on the behavior and pathology of mouse models of Parkinson's disease. METHODS: Eighteen C57 male mice were divided into a control group, subacute model group, and chronic...
Autores principales: | Ma, Yuanyuan, Rong, Qiongwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906981/ https://www.ncbi.nlm.nih.gov/pubmed/35299590 http://dx.doi.org/10.1155/2022/2112146 |
Ejemplares similares
-
Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent
por: Aktas, Busra
Publicado: (2023) -
Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson’s disease
por: Li, Qing, et al.
Publicado: (2021) -
The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018) -
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2015) -
Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease
por: Ma, Chunmei, et al.
Publicado: (2023)